vs

Side-by-side financial comparison of Metagenomi, Inc. (MGX) and Rocky Mountain Chocolate Factory, Inc. (RMCF). Click either name above to swap in a different company.

Rocky Mountain Chocolate Factory, Inc. is the larger business by last-quarter revenue ($7.5M vs $3.9M, roughly 1.9× Metagenomi, Inc.). Rocky Mountain Chocolate Factory, Inc. runs the higher net margin — -2.1% vs -576.0%, a 574.0% gap on every dollar of revenue. On growth, Rocky Mountain Chocolate Factory, Inc. posted the faster year-over-year revenue change (-4.4% vs -59.3%). Rocky Mountain Chocolate Factory, Inc. produced more free cash flow last quarter ($-1.3M vs $-23.6M). Over the past eight quarters, Rocky Mountain Chocolate Factory, Inc.'s revenue compounded faster (1.9% CAGR vs -40.8%).

Metagenomi, Inc. is a clinical-stage biotechnology company focused on developing metagenomics-powered gene editing therapeutics. It leverages massive microbial genome datasets to identify novel, precise CRISPR and alternative gene editing tools, advancing pipelines of in vivo and ex vivo therapies for both rare and common genetic diseases for global biopharma markets.

Rocky Mountain Chocolate, formerly Rocky Mountain Chocolate Factory, Inc., is an international franchiser, confectionery manufacturer and retail operator in the United States, with outlets in Panama and the Philippines. The company is based in the town of Durango, Colorado, United States of America.

MGX vs RMCF — Head-to-Head

Bigger by revenue
RMCF
RMCF
1.9× larger
RMCF
$7.5M
$3.9M
MGX
Growing faster (revenue YoY)
RMCF
RMCF
+54.9% gap
RMCF
-4.4%
-59.3%
MGX
Higher net margin
RMCF
RMCF
574.0% more per $
RMCF
-2.1%
-576.0%
MGX
More free cash flow
RMCF
RMCF
$22.4M more FCF
RMCF
$-1.3M
$-23.6M
MGX
Faster 2-yr revenue CAGR
RMCF
RMCF
Annualised
RMCF
1.9%
-40.8%
MGX

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MGX
MGX
RMCF
RMCF
Revenue
$3.9M
$7.5M
Net Profit
$-22.5M
$-155.0K
Gross Margin
34.0%
Operating Margin
-623.0%
1.1%
Net Margin
-576.0%
-2.1%
Revenue YoY
-59.3%
-4.4%
Net Profit YoY
3.7%
81.7%
EPS (diluted)
$-0.59
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MGX
MGX
RMCF
RMCF
Q4 25
$3.9M
$7.5M
Q3 25
$8.7M
$6.8M
Q2 25
$8.5M
$6.4M
Q1 25
$4.1M
$8.9M
Q4 24
$9.6M
$7.9M
Q3 24
$11.5M
$6.4M
Q2 24
$20.0M
$6.4M
Q1 24
$11.2M
$7.3M
Net Profit
MGX
MGX
RMCF
RMCF
Q4 25
$-22.5M
$-155.0K
Q3 25
$-20.4M
$-662.0K
Q2 25
$-19.9M
$-324.0K
Q1 25
$-25.0M
$-2.9M
Q4 24
$-23.4M
$-847.0K
Q3 24
$-18.8M
$-722.0K
Q2 24
$-10.7M
$-1.7M
Q1 24
$-25.1M
$-1.6M
Gross Margin
MGX
MGX
RMCF
RMCF
Q4 25
34.0%
Q3 25
23.6%
Q2 25
31.1%
Q1 25
10.8%
Q4 24
23.4%
Q3 24
31.8%
Q2 24
12.8%
Q1 24
24.3%
Operating Margin
MGX
MGX
RMCF
RMCF
Q4 25
-623.0%
1.1%
Q3 25
-263.8%
-7.0%
Q2 25
-246.5%
-2.3%
Q1 25
-674.1%
-30.3%
Q4 24
-214.5%
-8.9%
Q3 24
-194.4%
-14.3%
Q2 24
-84.3%
-25.4%
Q1 24
-260.2%
-21.7%
Net Margin
MGX
MGX
RMCF
RMCF
Q4 25
-576.0%
-2.1%
Q3 25
-235.5%
-9.7%
Q2 25
-233.9%
-5.1%
Q1 25
-606.7%
-32.5%
Q4 24
-243.4%
-10.7%
Q3 24
-163.0%
-11.3%
Q2 24
-53.7%
-25.9%
Q1 24
-225.4%
-21.9%
EPS (diluted)
MGX
MGX
RMCF
RMCF
Q4 25
$-0.59
$-0.02
Q3 25
$-0.55
$-0.09
Q2 25
$-0.54
$-0.04
Q1 25
$-0.68
$-0.38
Q4 24
$-0.37
$-0.11
Q3 24
$-0.51
$-0.11
Q2 24
$-0.29
$-0.26
Q1 24
$-1.19
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MGX
MGX
RMCF
RMCF
Cash + ST InvestmentsLiquidity on hand
$41.7M
$641.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$158.6M
$6.0M
Total Assets
$221.1M
$20.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MGX
MGX
RMCF
RMCF
Q4 25
$41.7M
$641.0K
Q3 25
$32.8M
$2.0M
Q2 25
$26.9M
$893.0K
Q1 25
$29.2M
$720.0K
Q4 24
$27.4M
$1.1M
Q3 24
$25.1M
$973.0K
Q2 24
$61.2M
$637.0K
Q1 24
$102.6M
$2.1M
Stockholders' Equity
MGX
MGX
RMCF
RMCF
Q4 25
$158.6M
$6.0M
Q3 25
$178.4M
$6.1M
Q2 25
$195.8M
$6.7M
Q1 25
$212.7M
$7.0M
Q4 24
$234.9M
$9.8M
Q3 24
$255.8M
$10.5M
Q2 24
$269.4M
$9.0M
Q1 24
$275.6M
$10.6M
Total Assets
MGX
MGX
RMCF
RMCF
Q4 25
$221.1M
$20.7M
Q3 25
$247.9M
$22.3M
Q2 25
$272.3M
$20.1M
Q1 25
$297.9M
$21.2M
Q4 24
$324.6M
$21.6M
Q3 24
$358.3M
$21.1M
Q2 24
$385.9M
$19.0M
Q1 24
$415.4M
$20.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MGX
MGX
RMCF
RMCF
Operating Cash FlowLast quarter
$-23.5M
$-1.2M
Free Cash FlowOCF − Capex
$-23.6M
$-1.3M
FCF MarginFCF / Revenue
-604.2%
-16.9%
Capex IntensityCapex / Revenue
2.2%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-89.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MGX
MGX
RMCF
RMCF
Q4 25
$-23.5M
$-1.2M
Q3 25
$-21.3M
$-488.0K
Q2 25
$-21.3M
$350.0K
Q1 25
$-22.8M
$1.2M
Q4 24
$-26.3M
$-2.1M
Q3 24
$-26.6M
$-3.5M
Q2 24
$-26.3M
$-2.2M
Q1 24
$-29.9M
$129.0K
Free Cash Flow
MGX
MGX
RMCF
RMCF
Q4 25
$-23.6M
$-1.3M
Q3 25
$-21.3M
$-544.0K
Q2 25
$-21.4M
$182.0K
Q1 25
$-23.1M
Q4 24
$-26.6M
Q3 24
$-27.8M
$-4.6M
Q2 24
$-27.0M
$-2.6M
Q1 24
$-30.8M
$-352.3K
FCF Margin
MGX
MGX
RMCF
RMCF
Q4 25
-604.2%
-16.9%
Q3 25
-246.3%
-8.0%
Q2 25
-251.1%
2.9%
Q1 25
-560.5%
Q4 24
-276.8%
Q3 24
-241.8%
-72.6%
Q2 24
-134.8%
-40.2%
Q1 24
-275.7%
-4.9%
Capex Intensity
MGX
MGX
RMCF
RMCF
Q4 25
2.2%
0.5%
Q3 25
0.9%
0.8%
Q2 25
1.5%
2.6%
Q1 25
7.0%
Q4 24
3.5%
Q3 24
10.4%
17.5%
Q2 24
3.3%
6.5%
Q1 24
8.2%
6.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MGX
MGX

Segment breakdown not available.

RMCF
RMCF

Manufacturing$5.9M78%
Transferred At Point In Time$1.2M16%
Other$414.0K5%

Related Comparisons